Reducing ocular damage in type 2 diabetes: the FIELD study shows fenofibrate benefits.
D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003930:Diabetic Retinopathy / Q000517:prevention & control*; D011345:Fenofibrate / Q000627:therapeutic use*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D000960:Hypolipidemic Agents; D011345:Fenofibrate